Understanding Clinician Knowledge, Attitudes, and Practices Relating to Nonpharmaceutical Fentanyl and Harm Reduction.
Understanding Clinician Knowledge, Attitudes, and Practices Relating to Nonpharmaceutical Fentanyl and Harm Reduction. Subst Use Addctn J. 2025 Jan; 46(1):120-126.
PMID: 39087695
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series. Addict Sci Clin Pract. 2023 06 01; 18(1):38.
PMID: 37264449
A Model to Improve Care and Enhance the Physician-Patient Relationship for Hospitalized Patients With Opioid Use Disorder.
A Model to Improve Care and Enhance the Physician-Patient Relationship for Hospitalized Patients With Opioid Use Disorder. Acad Med. 2023 06 01; 98(6S):S25-S27.
PMID: 36811966
Overcoming challenges in acute care hospitalizations for patients with opioid use disorder.
Overcoming challenges in acute care hospitalizations for patients with opioid use disorder. J Am Pharm Assoc (2003). 2023 Jan-Feb; 63(1):204-211.e2.
PMID: 36115762
Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.
Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19. J Healthc Qual. 2021 Jul-Aug 01; 43(4):195-203.
PMID: 34180868
Amantadine withdrawal syndrome masquerading as COVID-19 encephalopathy: a case report and review of the literature.
Amantadine withdrawal syndrome masquerading as COVID-19 encephalopathy: a case report and review of the literature. Oxf Med Case Reports. 2021 Feb; 2021(2):omaa133.
PMID: 33614044